Average Co-Inventor Count = 3.00
ph-index = 1
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cancer Prevention Pharmaceuticals, Inc. (4 from 5 patents)
4 patents:
1. 12350246 - Eflornithine and sulindac, fixed dose combination formulation
2. 11925613 - Eflornithine and sulindac, fixed dose combination formulation
3. 11529326 - Eflornithine and sulindac, fixed dose combination formulation
4. 10973790 - Eflornithine and sulindac, fixed dose combination formulation